BioCentury
ARTICLE | Clinical News

Endometrial Regenerative Cells: Preliminary Phase II data

April 1, 2013 7:00 AM UTC

Preliminary data from the double-blind, placebo-controlled, Russian Phase II RECOVER-ERC trial showed that no treatment-related adverse events were reported in 17 evaluable patients treated with ERCs....